IDL Biotech AB is a biotechnology company based in Bromma that specializes in the development of diagnostics for oncological and bacterial diseases. The company focuses on improving disease monitoring through innovative diagnostic technologies. By engaging in research and thesis projects, IDL Biotech aims to contribute to advancements in the field of diagnostics, which are crucial for enhancing healthcare outcomes.
The company has established partnerships with international organizations, including SISP in Indonesia, to broaden its impact and facilitate knowledge exchange. IDL Biotech actively participates in industry events such as Medica and Redeye, which allows them to stay informed about the latest developments in the biotechnology sector and collaborate with other professionals in the field. Their commitment to innovation and collaboration with educational institutions and hospitals underscores the importance they place on diagnostics in saving lives.